Tiger Brokers

  • Quotes
  • Products
    • Cash Boost Account
    • Singapore Stocks
    • US Stocks
    • US Fractional Shares
    • HK Stocks
    • China A-shares
    • Options
    • Futures
    • US Treasury
    • Auto-invest
    • Fixed Coupon Notes
    • Tiger BOSS Debit Card
    • Fund Mall
    • Tiger Vault
    • Tiger Open Platform
    • Wealth
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Tiger Vault
      • Features of Tiger Vault
      • Transaction Fees
    • Statement
      • Statement
      • Dividends
  • Learn
  • TigerAI
  • Institution
    • Wealth and asset manager
    • Proprietary trading institutions
    • Introducing brokers
    • Third-party service provider
  • Careers
    • L.E.A.P Programme
    • Investment Representative
    • Careers Portal
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Fintech (Singapore) Pte. Ltd.

Incyte

78.04
+2.453.24%
Post-market: 78.040.00000.00%16:10 EDT
Volume:1.62M
Turnover:125.24M
Market Cap:15.24B
PE:17.87
High:78.25
Open:75.77
Low:75.48
Close:75.59
Loading ...
OverviewCompanyNewsFilings

Concept

Renaissance Technologies Holdings+1.76%
Sequoia Capital Holdings+1.49%
ETF & Stock Investment+1.52%
Fractional Shares+1.52%

Capital Flow

 
Inflow:
 
Outflow:
 
 
 
 
 
 
 
 
 
 
 
 
 
 

News

Syndax Pharmaceuticals Reports Q2 2025 Net Loss of $71.8M, EPS of $0.83; Revuforj Sales Surge 43% Over Q1 2025

Reuters
·
12 mins ago

Incyte’s Promising Study Completion: Tafasitamab and Parsaclisib in B-cell Malignancies

TIPRANKS
·
4 hours ago

Incyte’s Phase 1 Study on INCB054707: A Potential Game-Changer for Hepatic Impairment

TIPRANKS
·
4 hours ago

Analysts Offer Insights on Healthcare Companies: Biogen (BIIB) and Incyte (INCY)

TIPRANKS
·
Yesterday

Analyst Rate

Buy
Buy
46.43%
Hold
50.00%
Sell
3.57%

Corporate Actions

Financial Report Announcement
Jul 29, 2025 Pre-Market
Financial Report Announcement
Apr 29, 2025 Pre-Market
Financial Report Announcement
Feb 10, 2025 Pre-Market
Financial Report Announcement
Oct 29, 2024 Pre-Market
Financial Report Announcement
Jul 30, 2024 Pre-Market

Dividend History

no data

No relevant data is available

Valuation Analysis

16.79
Current
85.07
Sector Average
21.09%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
16.79
Maximum
644.41
+1 STD
259.18
Minimum
-110.95
-1 STD
-89.04
Average
85.07

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Fintech (Singapore) Pte. Ltd.
Email Address:
uservice@ttm.financial
User Agreement|Privacy Policy

Copyright © Tiger Fintech (Singapore) Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.